Company Profile

Ubrigene (Beijing) biology technology co., LTD. (Ubrigene), established in October 2015, is a Hi-tech manufacturing biotech company and dedicated to the development and application of cell & AAV-centred gene therapy technologies, also to provide overall solutions for industrialization of gene therapy.

More about Ubrigene

CDMO service platform

Ubrigene is a forward-looking and large-scale manufacturing service platform for cell & gene therapy, which fully meets the requirements of regulations from design to operation of the plants. Ubrigene is capable of providing CDMO services covering development, manufacturing, and registration of cell & gene therapy candidates.

GMP plasmid
GMP AAV
GMP virus
Cell Banking services
Strain Banking services
CAR-T Preparation
More

CAR-T
Preparation Platform

Process
Development Platform

CAR-T
Preparation Platform

Process
Development Platform

Process
Development Platform

Innovation based on Quality

Ubrigene is committed to becoming a leader in biomedicine and health care industry, advancing the development of new drugs investigation, and making affordable cell & gene therapies to benefit more patients.

More Core Advantages

Company News

Search